One-year results published from STEM-PD trial for Parkinson's disease
A stem cell therapy designed to replace dopamine-producing nerve cells lost in Parkinson's disease has passed its first major clinical safety milestone...
A research study in which new ways to prevent, detect, diagnose, or treat disease are tested on human participants.
A stem cell therapy designed to replace dopamine-producing nerve cells lost in Parkinson's disease has passed its first major clinical safety milestone...
Transplanting neural stem/progenitor cells into people with recent spinal cord injuries has provided early evidence that the approach can be delivered safely, according to a first-in-human study published in Nature Medicine...
by BioNews
An experimental epigenome-editing therapy has shown a favourable safety profile and increased lean muscle mass in patients with a rare muscular dystrophy in an early-stage trial...
A drug candidate previously tested for safety in humans has reduced several disease-associated features in a mouse model of Alzheimer's disease...
An experimental autologous T cell therapy has shown encouraging early results in children with aggressive brain tumours...
The US Food and Drug Administration is allowing biotech company Regenxbio to reapply for licensing of a gene therapy for Hunter syndrome, in a reversal of its previous decision...
by Professor Lorenz Studer and 1 others
Professor Lorenz Studer and Tyler Lamb argue that existing ethical oversight enables responsible human embryonic stem cell research, and that continued NIH support is vital for regenerative medicine, disease modelling and new therapies...
by Xinran Hao
GLP-1 drugs may help to improve male testosterone levels and sperm count, preliminary research suggests...
An anti-ageing gene therapy not approved by the US Food and Drug Administration is set to be offered by an American company at overseas clinics outside of US jurisdiction...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.